NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 315 filers reported holding NATERA INC in Q2 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $11,638 | -11.1% | 263 | -2.2% | 0.00% | 0.0% |
Q2 2023 | $13,090 | -12.4% | 269 | 0.0% | 0.00% | -33.3% |
Q1 2023 | $14,935 | +41.4% | 269 | +2.3% | 0.00% | +50.0% |
Q4 2022 | $10,565 | +111.3% | 263 | +117.4% | 0.00% | +100.0% |
Q3 2022 | $5,000 | +400.0% | 121 | +365.4% | 0.00% | – |
Q2 2022 | $1,000 | -92.3% | 26 | -91.7% | 0.00% | -100.0% |
Q1 2022 | $13,000 | +550.0% | 314 | +1644.4% | 0.00% | – |
Q4 2021 | $2,000 | -84.6% | 18 | -84.7% | 0.00% | -100.0% |
Q3 2021 | $13,000 | +1200.0% | 118 | +883.3% | 0.00% | – |
Q2 2021 | $1,000 | 0.0% | 12 | +33.3% | 0.00% | – |
Q1 2021 | $1,000 | -50.0% | 9 | -43.8% | 0.00% | – |
Q4 2020 | $2,000 | +100.0% | 16 | +100.0% | 0.00% | – |
Q3 2020 | $1,000 | – | 8 | 0.0% | 0.00% | – |
Q2 2020 | $0 | – | 8 | 0.0% | 0.00% | – |
Q1 2020 | $0 | -100.0% | 8 | -57.9% | 0.00% | – |
Q4 2019 | $1,000 | 0.0% | 19 | 0.0% | 0.00% | – |
Q3 2019 | $1,000 | – | 19 | +90.0% | 0.00% | – |
Q2 2019 | $0 | – | 10 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 881,436 | $48,937,327 | 32.36% |
Kynam Capital Management, LP | 2,918,237 | $162,020,518 | 20.92% |
Sofinnova Investments, Inc. | 3,100,560 | $172,143,091 | 11.01% |
Eversept Partners, LP | 2,819,770 | $156,553,630 | 10.92% |
Eagle Health Investments LP | 784,894 | $43,577,315 | 8.48% |
Lagoda Investment Management, L.P. | 162,625 | $9,028,940 | 6.42% |
BEACONLIGHT CAPITAL, LLC | 204,567 | $11,357,560 | 6.00% |
Bain Capital Life Sciences Investors, LLC | 700,197 | $38,875 | 4.86% |
PERKINS CAPITAL MANAGEMENT INC | 62,700 | $3,481 | 3.28% |
RTW INVESTMENTS, LP | 2,611,783 | $145,006,192 | 3.02% |